Agrylin .5 mg/1
anagrelide hydrochloride · CAPSULE · Takeda Pharmaceuticals America, Inc.
Agrylin is a capsule containing anagrelide hydrochloride at .5 mg/1, taken oral. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Agrylin
- Generic Name
- anagrelide hydrochloride
- NDC Code (Product)
54092-063- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- .5 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA020333
- Marketing Start
- 03/14/1997
Recall History
No Recall HistoryFrequently Asked Questions
What is Agrylin used for?
Agrylin contains anagrelide hydrochloride. It is a capsule taken oral. Consult your doctor for specific uses.
Is Agrylin a controlled substance?
Agrylin is not classified as a controlled substance by the DEA.
What is the generic name for Agrylin?
The generic name for Agrylin is anagrelide hydrochloride. There are no other listed brand versions of anagrelide hydrochloride.
What is the NDC code for Agrylin .5 mg/1?
The NDC (National Drug Code) for Agrylin .5 mg/1 is 54092-063, listed by Takeda Pharmaceuticals America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)